These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 25058738)

  • 1. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020.
    Ford ES; Murphy LB; Khavjou O; Giles WH; Holt JB; Croft JB
    Chest; 2015 Jan; 147(1):31-45. PubMed ID: 25058738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029.
    Mannino DM; Roberts MH; Mapel DW; Zhang Q; Lunacsek O; Grabich S; van Stiphout J; Meadors BL; Feigler N; Pollack MF
    Chest; 2024 May; 165(5):1093-1106. PubMed ID: 38042365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-level medical and absenteeism cost of asthma in the United States.
    Nurmagambetov T; Khavjou O; Murphy L; Orenstein D
    J Asthma; 2017 May; 54(4):357-370. PubMed ID: 27715355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of Chronic Diseases at the State Level: The Chronic Disease Cost Calculator.
    Trogdon JG; Murphy LB; Khavjou OA; Li R; Maylahn CM; Tangka FK; Nurmagambetov TA; Ekwueme DU; Nwaise I; Chapman DP; Orenstein D
    Prev Chronic Dis; 2015 Sep; 12():E140. PubMed ID: 26334712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of schizophrenia in the United States in 2002.
    Wu EQ; Birnbaum HG; Shi L; Ball DE; Kessler RC; Moulis M; Aggarwal J
    J Clin Psychiatry; 2005 Sep; 66(9):1122-9. PubMed ID: 16187769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projecting Long-term Health and Economic Burden of COPD in the United States.
    Zafari Z; Li S; Eakin MN; Bellanger M; Reed RM
    Chest; 2021 Apr; 159(4):1400-1410. PubMed ID: 33011203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of the direct and indirect cost savings associated with heart disease that could be avoided through dietary change in the United States.
    Cawley J; Meyerhoefer C; Gillingham LG; Kris-Etherton P; Jones PJ
    J Med Econ; 2017 Feb; 20(2):182-192. PubMed ID: 27724055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective.
    Marton JP; Boulanger L; Friedman M; Dixon D; Wilson J; Menzin J
    Respir Med; 2006 Jun; 100(6):996-1005. PubMed ID: 16288858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden from smoking-related diseases in Thailand.
    Bundhamcharoen K; Aungkulanon S; Makka N; Shibuya K
    Tob Control; 2016 Sep; 25(5):532-7. PubMed ID: 26427527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State- and payer-specific estimates of annual medical expenditures attributable to obesity.
    Trogdon JG; Finkelstein EA; Feagan CW; Cohen JW
    Obesity (Silver Spring); 2012 Jan; 20(1):214-20. PubMed ID: 21681222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counting costs in COPD: what do the numbers mean?
    Mannino DM
    Chest; 2015 Jan; 147(1):3-5. PubMed ID: 25560850
    [No Abstract]   [Full Text] [Related]  

  • 12. The economic burden of major adult visual disorders in the United States.
    Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
    Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of occupational COPD and asthma.
    Leigh JP; Romano PS; Schenker MB; Kreiss K
    Chest; 2002 Jan; 121(1):264-72. PubMed ID: 11796461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-level cancer treatment costs: how much and who pays?
    Tangka FK; Trogdon JG; Ekwueme DU; Guy GP; Nwaise I; Orenstein D
    Cancer; 2013 Jun; 119(12):2309-16. PubMed ID: 23559348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.
    Strollo SE; Adjemian J; Adjemian MK; Prevots DR
    Ann Am Thorac Soc; 2015 Oct; 12(10):1458-64. PubMed ID: 26214350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Economic Burden of Asthma in the United States, 2008-2013.
    Nurmagambetov T; Kuwahara R; Garbe P
    Ann Am Thorac Soc; 2018 Mar; 15(3):348-356. PubMed ID: 29323930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the Economic Burden Related to Older Adult Falls by State.
    Haddad YK; Bergen G; Florence CS
    J Public Health Manag Pract; 2019; 25(2):E17-E24. PubMed ID: 29757813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Costs Attributable to Diabetes in Each U.S. State.
    Shrestha SS; Honeycutt AA; Yang W; Zhang P; Khavjou OA; Poehler DC; Neuwahl SJ; Hoerger TJ
    Diabetes Care; 2018 Dec; 41(12):2526-2534. PubMed ID: 30305349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National and state medical expenditures and lost earnings attributable to arthritis and other rheumatic conditions--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jan; 56(1):4-7. PubMed ID: 17218935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic costs of pain in the United States.
    Gaskin DJ; Richard P
    J Pain; 2012 Aug; 13(8):715-24. PubMed ID: 22607834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.